Mallinckrodt Plc (MNKKQ) Annual Balance Sheets

Annual · GAAP · USD millions
Access MNKKQ quarterly Balance Sheets →
Tracking balance sheet results across Mallinckrodt Plc to Dec 28 2018 helps illustrate how Dec 27 2024's financial position has responded to changing business conditions.
Annual Report, GAAP in USD millions
ITEM
(Dec 27 2024)
(Dec 31 2021) (Dec 25 2020) (Dec 27 2019) (Dec 28 2018)
Assets
Cash & cash equivalent319.00
Cash, Cash Equivalents Other21.50
Cash & Short-term Investments340.00
Accounts receivable121.30
Notes Receivable, Current54.40
Inventories313.90
Discontinued Operations608.10
Other Current Assets0.00
Prepaid Expense And Other Assets Current164.40
Total Current Assets1,526.70
Equipment/Property/Plant Net124.90
Intangible Assets171.70
Long-term investments41.60
Financial Instruments5.30
Tax Assets, Noncurrent8,681.20
Deferred, Prepaid and Other Assets, Noncurrent2.20
Discontinued operations, Noncurrent744.30
Other Assets, Noncurrent0.00
Total Assets3,302.60
Liabilities
Accounts Payable, Current AC32.70
Accrued Liabilities, Current75.40
Long-term Debt and Capital Lease Obligations, Current DE3.90
Other Liabilities, Current0.00
Taxes Payable5.90
Total Current Liabilities431.40
Long-term debt915.60
Secured Debt915.60
Long-term Debt Convertible50.00
Total Long-term Debt965.60
Combined Long+Short Total Debt (filer-reported)915.60
Financial Instruments, Insurance, Noncurrent1.30
Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent PE12.60
Deferred Tax Liabilities, Gross DE35.00
Discontinued Operation, Noncurrent133.20
Other liabilities, Noncurrent0.00
Total Liabilities1,656.80
Stockholders' Equity
Common Stock Value0.20
Treasury Stock Value0.00
Additional Paid In Capital Common Stock1,199.80
Retained Earnings / Accumulated Deficit439.70
Accumulated Other Comprehensive Income6.10
Other Equity6.10
Common Stockholder's Equity1,645.80
Total Stockholder's Equity1,645.80
Liabilities & Stockholder's Equity3,302.60
4 historic quarters locked

Sign in to unlock the full Mallinckrodt Plc balance sheet history.

About Keenova Therapeutics Plc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: April 15, 2026
  • Source: mnk-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-025238

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License